CND Life Sciences announces baseline results from Syn-Sleep Study to be presented at SLEEP 2025. iRBD is a sleep disorder that causes affected individuals to act out their dreams, often with violent ...
In a paper published in the Journal of the American Medical Association (JAMA), neurologists at Beth Israel Deaconess Medical Center (BIDMC) showed that a simple skin biopsy test detects an abnormal ...
Please provide your email address to receive an email when new articles are posted on . DENVER — Nearly all study participants believed to have a synucleinopathy had the presence of alpha-synuclein in ...
- Synuclein-One Study plenary session on Monday, April 15 at 9:15 a.m. MT will report the detection of cutaneous phosphorylated alpha-synuclein in patients with dementia with Lewy bodies and mild ...
To date, Parkinson's disease (PD) is diagnosed clinically and rather late in the course of the disease. There is an urgent need to find an objective, quantifiable biomarker for the diagnosis of this ...
Findings from retrospective chart review of patients with suspected Parkinson's disease and related disorders show the use of skin biopsy for detection of abnormal synuclein in cutaneous nerves ...
In a recent study published in JAMA, researchers evaluated the positivity rate of cutaneous phosphorylated alpha-synuclein protein (P-SYN) deposition among individuals with dementia with Lewy body ...
Please provide your email address to receive an email when new articles are posted on . A Phoenix-area medical technology company has received $4.2M grant fromThe Michael J. Fox Foundation for ...
BOSTON – In a paper published in the Journal of the American Medical Association (JAMA), neurologists at Beth Israel Deaconess Medical Center (BIDMC) showed that a simple skin biopsy test detects an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results